Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Research ArticleNuclear Oncology

Indium-111-DOTA-Lanreotide: Biodistribution, Safety and Radiation Absorbed Dose in Tumor Patients

Irene Virgolini, Istvan Szilvasi, Amir Kurtaran, Peter Angelberger, Markus Raderer, Ernst Havlik, Friedrich Vorbeck, Claudia Bischof, Maria Leimer, Guido Dorner, Kurt Kletter, Bruno Niederle, Werner Scheithauer and Peter Smith-Jones
Journal of Nuclear Medicine November 1998, 39 (11) 1928-1936;
Irene Virgolini
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Istvan Szilvasi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amir Kurtaran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Angelberger
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Markus Raderer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ernst Havlik
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Friedrich Vorbeck
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claudia Bischof
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Leimer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guido Dorner
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kurt Kletter
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bruno Niederle
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Werner Scheithauer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Smith-Jones
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading
PDF extract preview

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 39, Issue 11
November 1, 1998
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Indium-111-DOTA-Lanreotide: Biodistribution, Safety and Radiation Absorbed Dose in Tumor Patients
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Indium-111-DOTA-Lanreotide: Biodistribution, Safety and Radiation Absorbed Dose in Tumor Patients
Irene Virgolini, Istvan Szilvasi, Amir Kurtaran, Peter Angelberger, Markus Raderer, Ernst Havlik, Friedrich Vorbeck, Claudia Bischof, Maria Leimer, Guido Dorner, Kurt Kletter, Bruno Niederle, Werner Scheithauer, Peter Smith-Jones
Journal of Nuclear Medicine Nov 1998, 39 (11) 1928-1936;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Indium-111-DOTA-Lanreotide: Biodistribution, Safety and Radiation Absorbed Dose in Tumor Patients
Irene Virgolini, Istvan Szilvasi, Amir Kurtaran, Peter Angelberger, Markus Raderer, Ernst Havlik, Friedrich Vorbeck, Claudia Bischof, Maria Leimer, Guido Dorner, Kurt Kletter, Bruno Niederle, Werner Scheithauer, Peter Smith-Jones
Journal of Nuclear Medicine Nov 1998, 39 (11) 1928-1936;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Preclinical Comparison of 111In-Labeled DTPA- or DOTA-Bombesin Analogs for Receptor-Targeted Scintigraphy and Radionuclide Therapy
  • Targeted Cytotoxic Somatostatin Analogue AN-238 Inhibits Somatostatin Receptor-positive Experimental Colon Cancers Independently of Their p53 Status
  • Effects of Chemotherapeutic Agents on Expression of Somatostatin Receptors in Pancreatic Tumor Cells
  • 111In-DOTA-Lanreotide Scintigraphy in Patients with Tumors of the Lung
  • Inhibition of Metastatic Renal Cell Carcinomas Expressing Somatostatin Receptors by a Targeted Cytotoxic Analogue of Somatostatin AN-238
  • Google Scholar

More in this TOC Section

  • Dose Escalation Trial of Indium-111-Labeled Anti-Carcinoembryonic Antigen Chimeric Monoclonal Antibody (Chimeric T84.66) in Presurgical Colorectal Cancer Patients
  • Optimized Conditions for Chelation of Yttrium-90-DOTA Immunoconjugates
  • Quantifying the Radiation Dosage to Individual Skeletal Lesions Treated with Samarium-153-EDTMP
Show more Nuclear Oncology

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire